Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03878095
Title Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 United States Details
Smilow Cancer Center/Yale-New Haven Hospital New Haven Connecticut 06510 United States Details
Yale University New Haven Connecticut 06520 United States Details
Smilow Cancer Hospital Care Center-Trumbull Trumbull Connecticut 06611 United States Details
University of Florida Health Science Center - Gainesville Gainesville Florida 32610 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field